BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Laryngoscope
,
Lipopolysaccharide
,
rs7903146
,
PRKCA
,
calcium channel activity
,
Lung
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
ba 2
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Pro-B BAF-3 cells overexpressing MPL[W515L] and treated with JAK2 inhibitor INCB18424
Drug Matrix In Vivo Toxicogenomic Study - Rat Kidney [Codelink]
Drug Matrix In Vivo Toxicogenomic Study - Rat Heart [Codelink]
Drug Matrix In Vivo Toxicogenomic Study - Rat Kidney [Affymetrix]
Drug Matrix In Vivo Toxicogenomic Study - Rat Liver [Affymetrix]
Explore Curated Studies Results
Literature
Most Relevant Literature
Characterization of SARS-CoV-2 Omicron BA.2.75 clinical isolates.
A delicate balance between antibody evasion and ACE2 affinity for Omicron BA.2.75.
Selective SARS-CoV2 BA.2 escape of antibody Fc/Fc-receptor interactions.
Serum neutralization of SARS-CoV-2 Omicron BA.2, BA.2.75, BA.2.76, BA.5, BF.7, BQ.1.1 and XBB.1.5 in…
Structural analysis of receptor engagement and antigenic drift within the BA.2 spike protein.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Safety, Tolerability and Immunogenicity of Alveavax-v1.2, a BA.2/Omicron-optimized, DNA Vaccine for …
A Cohort Study of SARS-CoV-2 Variant (Omicron BA.5) mRNA Vaccine in Participants Aged 18 Years and O…
A Study to Evaluate the Efficacy, Safety, and Immunogenicity of SARS-CoV-2 Variant (BA.4 /5) mRNA Va…
A Preliminary Exploratory Cohort Study of SARS-CoV-2 Variant (Omicron BA.5) mRNA Vaccine in Particip…
Clinical Trial of COVID-19 Vaccine(SARS-CoV-2 Variant(Omicron BA.5) mRNA Vaccine) in Participants Ag…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ